Clinical trial
Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
NCT00200941 · Neurocare, Other · Completed
Key facts
| NCT number | NCT00200941 |
|---|---|
| Title | Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS) |
| Lead sponsor | Neurocare, Other |
| Collaborators | Ortho-McNeil Pharmaceutical Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 44 |
| Start date | Aug 1, 2001 |
| Completion | Apr 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: